References
- Levine RA. Echocardiographic assessment of the cardiomyopathies. In: Weyman AE. Principles and practice of echocardiography. 2d ed. Philadelphia: Lea & Febinger, 1994: 781-804
- Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995; 92(5): 1336-47
- Braunwald E. Valvular heart disease. In: Braunwald E. Heart disease: a text book of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997: 1007-77
- Nishimura RA, Giuliani ER, Brandenburg RO, et al. Hypertrophic cardiomyopathy. In: Giuliani ER, Gersh BJ, McGoon MG, et al. Mayo Clinic practice of cardiology. 3d ed. St Louis: Mosby, 1996: 689-711
- Oh JK, Seward JB, Tajik AJ. Cardiomyopathies. In: Oh JK, Seward JB, Tajik AJ. The echo manual. 2d ed. Philadelphia: Lippincott-Raven, 1999: 156-63
- Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996; 94(4): 850-6
- Yu B, French JA, Jeremy RW, et al. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genet 1998; 35(3): 183-8
- Slade AK, Camm AJ. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Arch Mal Coeur Vaiss 1996; 89 Spec No 1: 37-49
- Fananapazir L, McAreavey D. Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death. Pacing Clin Electrophysiol 1997; 20(2 Pt 2): 478-501
- Marian AJ. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers. Clin Cardiol 1995; 18(4): 189-98
- Spirito P, Seidman CD, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336(11): 775-85
- Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350(9071): 127-33
- Louie EK, Edwards LC 3d. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 1994; 36(4): 275-308
- Zhu DW, Sun H, Hill R, et al. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998; 21(1 Pt 2): 299-302
- Kuck KH. Arrhythmias in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1997; 20(10 Pt 2): 2706-13
- Task Force on Practice Guidelines Committee on Management of Patients with Valvular Heart Disease. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association. J Am Coll Cardiol 1998; 32(5): 1486-588
- Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy: a randomized crossover study. Eur Heart J 1997; 18(8): 1249-56
- Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29(2): 435-41
- Fananapazir L, McAreavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. (Editorial) J Am Coll Cardiol 1998; 31(2): 259-64
- Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998; 31(2): 252-8
- Hasegawa K, Fujiwara H, Doyama K, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993; 88(2): 372-80